Hearing Loss Clinical Trials 2024

Hearing Loss Clinical Trials 2024

Hearing Loss research studies recruiting patients in 2024 need your help. Receive premium care & cutting edge treatments by enrolling in hearing loss clinical trials today.

Hearing Loss Clinical Trials

Here are the 6 most popular medical studies for hearing loss

Popular filter options for hearing loss trials

Sensorineural Hearing Loss Clinical Trials

View 72 Sensorineural Hearing Loss medical studies.

SPHL Clinical Trials

View 62 SPHL medical studies.

Hearing Loss Clinical Trials With No Placebo

View 99 hearing loss medical studies that do not have a placebo group.

View More Hearing Loss Trials

See another 82 medical studies focused on hearing loss.

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.

Introduction to hearing loss

What are the top hospitals conducting hearing loss research?

When it comes to advancing the field of hearing loss research, several top hospitals are leading the way. The Vanderbilt University Medical Center in Nashville is at the forefront with five active clinical trials dedicated to understanding and treating hearing loss. With a total of 15 trials conducted since their first recorded trial in 2011, this institution's commitment to finding innovative solutions is evident. In Jackson, Mississippi, the University of Mississippi Medical Center has made significant contributions as well. Currently conducting four active hearing loss trials and having completed three previous studies since recording their first trial in 2019, they are actively working towards improving outcomes for individuals affected by hearing impairment.

Nationwide Children's Hospital in Columbus also plays a crucial role with its ongoing dedication to hearing loss research. They currently have four active clinical trials focused on better understanding this condition and find ways to offer effective interventions. Having started their initial trial only three years ago in 2018, they have quickly established themselves as key players in this field.

The University of Iowa in Iowa City joins these institutions' efforts by devoting resources to studying and addressing hearing loss through four ongoing clinical trials. Their involvement spans over sixteen years since initiating their first recorded trial on this subject back in 2004 resultingin fourteen various experiments held till date.Their work contributes significantly towards expanding our knowledge about this prevalent condition.

Lastly, we turn our attention to Los Angeles where the renowned University of Southern California is making notable strides against hearing loss with its current portfolio of four active clinical trials. Despite joining the pursuit most recently with its inaugural trial starting just last year (2020), they already make a meaningful impact alongside other established institutions across different regions.

Together, these hospitals represent beacons of hope for those experiencing auditory challenges while highlighting that advancements can occur from diverse locations across America By continuously pushing boundaries through groundbreaking research endeavors; we move closer towards improving prevention strategies,treatments,and ultimately enhancing quality life experiencesfor countless individuals struggling with hearing loss.

Which are the best cities for hearing loss clinical trials?

When it comes to hearing loss clinical trials, several cities emerge as top contenders for groundbreaking research. New york leads the pack with 16 active trials investigating treatments such as Valganciclovir, Ebselen, and Vagal Nerve Stimulation during Cochlear Implantation Surgery. Los Angeles follows closely behind with 11 ongoing studies focusing on interventions like Ebselen, Montelukast, and Voice lessons. Saint Louis showcases promising research with 10 active trials exploring treatment options ranging from chemoradiotherapy to Electrocochleography. Chicago also plays a significant role in hearing loss research with 9 active trials studying Hearing Aids, DTC Hearing Aid, and Valganciclovir among others. Lastly, Seattle contributes to the field with 8 active trials that investigate various interventions including Usual Care + Teletherapy (Low-Income) and DB-OTO - Dose Escalation. These cities provide individuals experiencing hearing loss access to cutting-edge clinical trials that pave the way for improved care and potential breakthroughs in this domain of healthcare.

Which are the top treatments for hearing loss being explored in clinical trials?

The quest to find effective treatments for hearing loss is ongoing, fueled by innovative research and clinical trials. Among the top contenders is an experimental treatment currently being explored in two active trials specifically focused on hearing loss. This pioneering therapy made its debut in 2012 and has since accumulated one all-time trial dedicated to addressing this challenging condition. As scientists continue their efforts, these clinical trials offer hope for advancements that could transform the lives of individuals affected by hearing loss worldwide.

What are the most recent clinical trials for hearing loss?

Recent clinical trials offer hope for individuals with hearing loss, as researchers explore innovative approaches to address this prevalent condition. One such trial focuses on the effectiveness of high-dose ORC-13661 in treating hearing loss, with promising results emerging from Phase 2 studies. Additionally, DB-OTO aims to evaluate dose escalation and its impact on mitigating hearing loss through combined Phase 1 and Phase 2 investigations. Cohort 2 is another study that investigates potential treatments for hearing loss across different phases of research. Furthermore, a noteworthy trial examines the efficacy of standard cisplatin-based chemotherapy when combined with sodium thiosulfate and mannitol for addressing hearing loss concerns. Finally, a Phase 4 trial explores statin usage as an intervention strategy against hearing loss. These diverse clinical trials demonstrate the commitment of scientists towards finding effective solutions for improving auditory health in those affected by hearing impairment.

What hearing loss clinical trials were recently completed?

Several clinical trials focusing on hearing loss have recently been completed, offering insights into potential treatments and advancements in this field. These trials include the study of a new medication sponsored by Stanford University School of Medicine, which concluded in November 2021. Another trial exploring innovative gene therapy for hearing loss was successfully conducted by the University of Miami Miller School of Medicine, concluding in September 2021. The completion of these trials brings us closer to better understanding and addressing hearing loss, providing hope for those affected by this condition.